Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q SECOND QUARTER 2016 - CHEMBIO DIAGNOSTICS, INC. | form10q.htm |
| EX-31.2 - CFO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_2q.htm |
| EX-31.1 - CEO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_1q.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q (the "Report") of Chembio Diagnostics, Inc. (the "Company") for the quarter ended June 30, 2016, each of the undersigned John J. Sperzel III, the Chief Executive Officer of the Company, and Richard J. Larkin, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds' knowledge and belief:
(1) This Form 10-Q for the quarter ended June 30, 2016 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in this Form 10-Q for the quarter ended June 30, 2016 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.
Dated: August 11, 2016 /s/ John J. Sperzel III
John J. Sperzel III
Chief Executive Officer
Dated: August 11, 2016 /s/ Richard J. Larkin
Richard J. Larkin
Chief Financial Officer